ABCT Participant Directory

Jacob V.P. Eswarakumar

Eswarakumar Headshot picture

Krouzon Pharmaceuticals, Inc

2019

Affiliations

Yale University

Technologies

Therapeutic

Indication

Developmental Disorders

Orphan Diseases

Executive Summary

View/Download

Krouzon Pharmaceuticals, Inc. is developing a first-in-class treatment for ultra-rare orphan pediatric skeletal disorders.

Contact ABCT

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

For more information about Corporate Support and Community Service Provider Support, please contact our Senior Program Manager, Maggie El Naamani at maggie@firstxfounder.com

Program of

Initiated by